Search

Your search keyword '"Patterson AR"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Patterson AR" Remove constraint Author: "Patterson AR"
68 results on '"Patterson AR"'

Search Results

1. Cell-programmed nutrient partitioning in the tumour microenvironment

2. RESISTANCE TO PURINE RIBONUCLEOSIDE ANALOGUES IN AN ASCITES TUMOR

Catalog

Books, media, physical & digital resources

4. Examining gender-specific mental health risks after gender-affirming surgery: a national database study.

5. Influences on decision-making for gender-affirming surgery in adolescents: A scoping review of family, religion, and healthcare provider factors.

6. Molecular and Clinical Characterization of a Founder Mutation Causing G6PC3 Deficiency.

7. Subset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammation.

8. Functional overlap of inborn errors of immunity and metabolism genes defines T cell metabolic vulnerabilities.

9. Mitochondrial Fatty Acid Synthesis and Mecr Regulate CD4+ T Cell Function and Oxidative Metabolism.

10. Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in Inflammation.

11. Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells.

12. Rapid and Reversible Lithium Insertion in the Wadsley-Roth-Derived Phase NaNb 13 O 33 .

13. Functional Overlap of Inborn Errors of Immunity and Metabolism Genes Define T Cell Immunometabolic Vulnerabilities.

14. Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk.

15. Cell-programmed nutrient partitioning in the tumour microenvironment.

16. An industrial perspective on co-crystals: Screening, identification and development of the less utilised solid form in drug discovery and development.

17. Loss of GTPase of immunity-associated protein 5 (Gimap5) promotes pathogenic CD4 + T-cell development and allergic airway disease.

18. Evaluation of the pathogenicity of mammalian orthoreovirus type 3 (MRV3) in germ-free gnotobiotic pigs and of the efficacy of an inactivated vaccine against MRV3 infection in neonatal conventional piglets.

19. Pyrene hydrogel for promoting direct bioelectrochemistry: ATP-independent electroenzymatic reduction of N 2 .

20. Detection of atypical porcine pestivirus in semen from commercial boar studs in the United States.

21. Gimap5-dependent inactivation of GSK3β is required for CD4 + T cell homeostasis and prevention of immune pathology.

22. Prevalence of the Novel Torque Teno Sus Virus Species k2b from Pigs in the United States and Lack of Association with Post-Weaning Multisystemic Wasting Syndrome or Mulberry Heart Disease.

23. Identification of a Divergent Lineage Porcine Pestivirus in Nursing Piglets with Congenital Tremors and Reproduction of Disease following Experimental Inoculation.

24. Sustained reprogramming of the estrogen response after chronic exposure to endocrine disruptors.

25. Disability training in the genetic counseling curricula: bridging the gap between genetic counselors and the disability community.

27. Models provide specificity: Testing a proposed mechanism of visual working memory capacity development.

28. Rescue of a porcine anellovirus (torque teno sus virus 2) from cloned genomic DNA in pigs.

29. Trp RNA-binding attenuation protein: modifying symmetry and stability of a circular oligomer.

30. Shedding and infection dynamics of porcine circovirus type 2 (PCV2) after experimental infection.

31. Shedding and infection dynamics of porcine circovirus type 2 (PCV2) after natural exposure.

32. Interlaboratory comparison of Porcine circovirus-2 indirect immunofluorescent antibody test and enzyme-linked immunosorbent assay results on experimentally infected pigs.

33. Epidemiology and horizontal transmission of porcine circovirus type 2 (PCV2).

34. Efficacy of experimentally produced spray-dried plasma on infectivity of porcine circovirus type 2.

35. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination.

36. Tapia's syndrome after repair of a fractured mandible.

37. Effect of natural or vaccine-induced porcine circovirus type 2 (PCV2) immunity on fetal infection after artificial insemination with PCV2 spiked semen.

38. Evaluation of the safety of four porcine circovirus type 2 tissue homogenate vaccines in a pig bioassay.

39. Reproductive failure experimentally induced in sows via artificial insemination with semen spiked with porcine circovirus type 2.

40. Naturally occurring influenza infection in a ferret (Mustela putorius furo) colony.

41. Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero.

42. Difference in severity of porcine circovirus type two-induced pathological lesions between Landrace and Pietrain pigs.

43. Limited susceptibility of three different mouse (Mus musculus) lines to Porcine circovirus-2 infection and associated lesions.

44. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination.

45. Ganglioneuroma of the mandible resulting from metastasis of neuroblastoma.

46. Porcine circovirus type 2 in muscle and bone marrow is infectious and transmissible to naïve pigs by oral consumption.

47. Comparison of three enzyme-linked immunosorbent assays to detect Porcine circovirus-2 (PCV-2)-specific antibodies after vaccination or inoculation of pigs with distinct PCV-1 or PCV-2 isolates.

48. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection.

50. Septic arthritis of the temporomandibular joint in a 6-year-old child.